Zobrazeno 1 - 10
of 52
pro vyhledávání: '"Chang-qian Wang"'
Publikováno v:
International Journal of Cardiology: Heart & Vasculature, Vol 50, Iss , Pp 101353- (2024)
Background: Although prophylactic anticoagulation therapy is suggested to be adopted in severe COVID-19 patients, its effects on the long-term cardiovascular (CV) outcomes, namely the risk of major adverse CV events(MACEs) in high-risk CV patients am
Externí odkaz:
https://doaj.org/article/6ea013abfd344991bbf0817d28b87747
Autor:
Bo-Yan Chen, Wen-Zhen Lin, Yu-Lin Li, Chao Bi, Lin-Juan Du, Yuan Liu, Lu-Jun Zhou, Ting Liu, Shuo Xu, Chao-Ji Shi, Hong Zhu, Yong-Li Wang, Jian-Yong Sun, Yan Liu, Wu-Chang Zhang, Hai-Xia Lu, Yi-Hua Wang, Qiang Feng, Fu-Xiang Chen, Chang-Qian Wang, Maurizio S. Tonetti, Ya-Qin Zhu, Huili Zhang, Sheng-Zhong Duan
Publikováno v:
Journal of Advanced Research, Vol 43, Iss , Pp 147-161 (2023)
Introduction: Considerable evidence has linked periodontitis (PD) to hypertension (HTN), but the nature behind this connection is unclear. Dysbiosis of oral microbiota leading to PD is known to aggravate different systematic diseases, but the alterat
Externí odkaz:
https://doaj.org/article/71033037bd794f0dab07ee9d7a79ad79
Autor:
Xiao-Fei Wang, Meng-Cheng Xu, Cheng-Yu Mao, En-Zhou, Qing He, Xing-Qian Qu, Yu-Qi Fan, Chang-Qian Wang, Jun-Feng Zhang
Publikováno v:
Reviews in Cardiovascular Medicine, Vol 22, Iss 3, Pp 1009-1017 (2021)
The aim of this study was to investigate the correlation between v-set and transmembrane domain-containing 1 (VSTM1) expression and incidence of major adverse cardiac events (MACE) in patients with coronary heart disease (CHD). A total of 310 patient
Externí odkaz:
https://doaj.org/article/c7de0af69e9e4887a5e9ebc862cbbe21
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 9 (2022)
BackgroundHeart failure with preserved ejection fraction (HFpEF) patients varied by left ventricular ejection fraction (LVEF) have different clinical characteristics, prognosis, and treatment response. With data from our prospective HFpEF cohort, we
Externí odkaz:
https://doaj.org/article/7b4f0841592e44938662c47e5128d37f
Publikováno v:
ESC Heart Failure, Vol 8, Iss 4, Pp 2784-2790 (2021)
Abstract Aims Heart failure with preserved ejection fraction (HFpEF) develops in response to hypertensive left ventricular (LV) hypertrophy and is associated with increased cardiovascular events. Although the progression to systolic heart failure is
Externí odkaz:
https://doaj.org/article/14280e335ee849a6b8242efb2064dfc8
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 9 (2022)
BackgroundIn patients with both heart failure with preserved ejection fraction (HFpEF) and coronary artery disease (CAD), whether adopting an initial invasive strategy benefits better in clinical outcomes compared with those who received an initial c
Externí odkaz:
https://doaj.org/article/dea9f2fe23cb44c092f23b886a75d93e
Publikováno v:
ESC Heart Failure, Vol 7, Iss 2, Pp 616-625 (2020)
Abstract Aims Patients with heart failure (HF) are typically designated as having reduced, mid‐range, or preserved ejection fraction (EF) (HFrEF, HFmrEF, or HFpEF, respectively) because of the importance of left ventricular EF (LVEF) on therapeutic
Externí odkaz:
https://doaj.org/article/90781c9cb0164e108ff5075ef9a03585
Autor:
Jian-an Pan, Hui Zhang, Hao Lin, Lin Gao, Hui-li Zhang, Jun-feng Zhang, Chang-qian Wang, Jun Gu
Publikováno v:
Redox Biology, Vol 46, Iss , Pp 102120- (2021)
The dose-dependent toxicity to cardiomyocytes has been well recognized as a central characteristic of doxorubicin (DOX)-induced cardiotoxicity (DIC), however, the pathogenesis of DIC in the cardiac microenvironment remains elusive. Irisin is a new ho
Externí odkaz:
https://doaj.org/article/dcc8d7314c5d4adfb046c086012c095c
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 8 (2021)
Background: The contemporary incidence of heart failure (HF) in patients with coronary artery disease (CAD) undergoing percutaneous coronary intervention (PCI) remains unclear. This prospective cohort study was designed to study the incidence and pre
Externí odkaz:
https://doaj.org/article/66ca5fa470d2425aa37b57686f3c982b
Autor:
Jun Gu, Yang Zhuo, Tian-jiao Liu, Jie Li, Zhao-fang Yin, Zuo-jun Xu, Li Fan, Qing He, Kan Chen, Hua-su Zeng, Xiao-fei Wang, Yu-qi Fan, Jun-feng Zhang, Fu-you Liang, Chang-qian Wang
Publikováno v:
Cardiology Research and Practice, Vol 2020 (2020)
Background. Primary percutaneous coronary intervention (PCI) is the best available reperfusion strategy in patients with acute ST-segment elevation myocardial infarction (STEMI). However, PCI is associated with a serious problem known as no-reflow ph
Externí odkaz:
https://doaj.org/article/c26c7460aa25411cb27c0c4c9a4bf306